These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 33406505)
41. GSK-3β and ERK1/2 incongruously act in tau hyperphosphorylation in SPS-induced PTSD rats. Wei Z; Mahaman YAR; Zhu F; Wu M; Xia Y; Zeng K; Yang Y; Liu R; Wang JZ; Shu X; Wang X Aging (Albany NY); 2019 Sep; 11(18):7978-7995. PubMed ID: 31548435 [TBL] [Abstract][Full Text] [Related]
42. Modulation of GSK-3β/β-Catenin Signaling Contributes to Learning and Memory Impairment in a Rat Model of Depression. Hui J; Zhang J; Pu M; Zhou X; Dong L; Mao X; Shi G; Zou J; Wu J; Jiang D; Xi G Int J Neuropsychopharmacol; 2018 Sep; 21(9):858-870. PubMed ID: 29688389 [TBL] [Abstract][Full Text] [Related]
43. Piperine regulates glycogen synthase kinase-3β-related signaling and attenuates cognitive decline in D-galactose-induced aging mouse model. Wang C; Cai Z; Wang W; Wei M; Si X; Shang Y; Yang Z; Li T; Guo H; Li S J Nutr Biochem; 2020 Jan; 75():108261. PubMed ID: 31710934 [TBL] [Abstract][Full Text] [Related]
44. Activation of tau protein kinase I/glycogen synthase kinase-3beta by amyloid beta peptide (25-35) enhances phosphorylation of tau in hippocampal neurons. Takashima A; Honda T; Yasutake K; Michel G; Murayama O; Murayama M; Ishiguro K; Yamaguchi H Neurosci Res; 1998 Aug; 31(4):317-23. PubMed ID: 9809590 [TBL] [Abstract][Full Text] [Related]
45. The molecular mechanisms of signal pathway activating effect of E2F-1/NF-κB/GSK-3β on cognitive dysfunction of Alzheimer rats. Tuerxun M; Muhda A; Yin L Bioengineered; 2021 Dec; 12(2):10000-10008. PubMed ID: 34839794 [TBL] [Abstract][Full Text] [Related]
46. miR-124-3p promotes BMSC osteogenesis via suppressing the GSK-3β/β-catenin signaling pathway in diabetic osteoporosis rats. Li Z; Zhao H; Chu S; Liu X; Qu X; Li J; Liu D; Li H In Vitro Cell Dev Biol Anim; 2020 Oct; 56(9):723-734. PubMed ID: 33085064 [TBL] [Abstract][Full Text] [Related]
47. Inhibition of glycogen synthase kinase-3 reverses tau hyperphosphorylation induced by Pin1 down-regulation. Xiong YS; Wang DL; Tan L; Wang X; Chen LM; Gong CX; Wang JZ; Zhu LQ CNS Neurol Disord Drug Targets; 2013 May; 12(3):436-43. PubMed ID: 23469846 [TBL] [Abstract][Full Text] [Related]
48. Dysregulation of miRNAs Levels in Glycogen Synthase Kinase-3β Overexpressing Mice and the Role of miR-221-5p in Synaptic Function. Banach E; Szczepankiewicz A; Kaczmarek L; Jaworski T; Urban-Ciećko J Neuroscience; 2022 May; 490():287-295. PubMed ID: 35331845 [TBL] [Abstract][Full Text] [Related]
49. Acetyl-L-carnitine ameliorates spatial memory deficits induced by inhibition of phosphoinositol-3 kinase and protein kinase C. Jiang X; Tian Q; Wang Y; Zhou XW; Xie JZ; Wang JZ; Zhu LQ J Neurochem; 2011 Sep; 118(5):864-78. PubMed ID: 21689104 [TBL] [Abstract][Full Text] [Related]
50. Stimulation of EphB2 attenuates tau phosphorylation through PI3K/Akt-mediated inactivation of glycogen synthase kinase-3β. Jiang J; Wang ZH; Qu M; Gao D; Liu XP; Zhu LQ; Wang JZ Sci Rep; 2015 Jun; 5():11765. PubMed ID: 26119563 [TBL] [Abstract][Full Text] [Related]
52. [Effect of rutaecarpine on Alzheimer's disease-like cognitive impairments induced by high glucose in rats]. Chen JG; Wu YG; Li X Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2019 Feb; 35(2):178-182. PubMed ID: 31250613 [TBL] [Abstract][Full Text] [Related]
53. Calycosin ameliorates diabetes-induced cognitive impairments in rats by reducing oxidative stress via the PI3K/Akt/GSK-3β signaling pathway. Wang X; Zhao L Biochem Biophys Res Commun; 2016 Apr; 473(2):428-34. PubMed ID: 26970304 [TBL] [Abstract][Full Text] [Related]
54. Mori Fructus improves cognitive and neuronal dysfunction induced by beta-amyloid toxicity through the GSK-3β pathway in vitro and in vivo. Kim HG; Park G; Lim S; Park H; Choi JG; Jeong HU; Kang MS; Lee MK; Oh MS J Ethnopharmacol; 2015 Aug; 171():196-204. PubMed ID: 26068423 [TBL] [Abstract][Full Text] [Related]
55. Intranasal insulin ameliorates tau hyperphosphorylation in a rat model of type 2 diabetes. Yang Y; Ma D; Wang Y; Jiang T; Hu S; Zhang M; Yu X; Gong CX J Alzheimers Dis; 2013; 33(2):329-38. PubMed ID: 22936005 [TBL] [Abstract][Full Text] [Related]
56. Chronic lithium administration to FTDP-17 tau and GSK-3beta overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert. Engel T; Goñi-Oliver P; Lucas JJ; Avila J; Hernández F J Neurochem; 2006 Dec; 99(6):1445-55. PubMed ID: 17059563 [TBL] [Abstract][Full Text] [Related]
57. Role of S-nitrosoglutathione mediated mechanisms in tau hyper-phosphorylation. Annamalai B; Won JS; Choi S; Singh I; Singh AK Biochem Biophys Res Commun; 2015 Feb; 458(1):214-9. PubMed ID: 25640839 [TBL] [Abstract][Full Text] [Related]
58. Cadmium-induced cell death of basal forebrain cholinergic neurons mediated by muscarinic M1 receptor blockade, increase in GSK-3β enzyme, β-amyloid and tau protein levels. Del Pino J; Zeballos G; Anadón MJ; Moyano P; Díaz MJ; García JM; Frejo MT Arch Toxicol; 2016 May; 90(5):1081-92. PubMed ID: 26026611 [TBL] [Abstract][Full Text] [Related]
59. LiCl attenuates thapsigargin-induced tau hyperphosphorylation by inhibiting GSK-3β in vivo and in vitro. Fu ZQ; Yang Y; Song J; Jiang Q; Lin ZC; Wang Q; Zhu LQ; Wang JZ; Tian Q J Alzheimers Dis; 2010; 21(4):1107-17. PubMed ID: 21504119 [TBL] [Abstract][Full Text] [Related]
60. GSK-3β downregulates Nrf2 in cultured cortical neurons and in a rat model of cerebral ischemia-reperfusion. Chen X; Liu Y; Zhu J; Lei S; Dong Y; Li L; Jiang B; Tan L; Wu J; Yu S; Zhao Y Sci Rep; 2016 Feb; 6():20196. PubMed ID: 26838164 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]